MTOR and breast cancer: For instance, the H1047R mutation in the oncogenic PIK3CA gene in breast cancer enhances PI3K enzyme activity, activating the AKT/mTOR signalling pathway and inducing the glycosylation of membrane metalloendopeptidase, ultimately resulting in tumour cell senescence.14